{
    "Trade/Device Name(s)": [
        "DRG SLV Testosterone ELISA",
        "DRG Salivary Testosterone ELISA"
    ],
    "Submitter Information": "DRG International, Inc.",
    "510(k) Number": "K052649",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "January 27, 2006",
    "Summary Letter Received Date": "January 9, 2006",
    "Submission Date": "December 27, 2005",
    "Regulation Number(s)": [
        "21CFR862.1680"
    ],
    "Regulation Name(s)": [
        "Testosterone test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Testosterone"
    ],
    "Specimen Type(s)": [
        "Saliva"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Microplate competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for DRG SLV Testosterone ELISA kit for quantitative measurement of free active testosterone in saliva using enzyme immunoassay.",
    "Indications for Use Summary": "Quantitative measurement of free active testosterone in saliva for diagnosis and treatment of disorders involving male sex hormones, including hypogonadism, puberty disorders, impotence, hirsutism, virilization, tumors, polycystic ovaries, and adrenogenital syndromes.",
    "fda_folder": "Clinical Chemistry"
}